12-Panel Drug Test for Comprehensive Urine Screening

Reliable Multi-Drug Screening in One Convenient Test

Make routine drug screening simpler with a 12-panel urine drug test designed for efficient, easy-to-use preliminary screening. Ideal for workplaces, clinics, healthcare providers, treatment programs, and other authorized testing environments, this multi-panel format provides a convenient way to screen for multiple commonly monitored drug classes from a single urine specimen.

Our 12-panel drug test is designed for straightforward specimen collection and rapid preliminary results, helping authorized testing professionals streamline their screening workflow without unnecessary complexity.

What Does a 12-Panel Drug Test Detect?

The exact substances included depend on the specific test configuration. Common 12-panel configurations may include drug classes such as amphetamines, methamphetamine, cocaine, cannabinoids (THC), opioids, benzodiazepines, barbiturates, methadone, oxycodone, PCP, and other specified substances.

Importantly, not every prescription medication belongs to one of these standard panels. Ritalin (methylphenidate), for example, is not generally detected by a routine amphetamine screen. Dedicated laboratory testing can specifically identify methylphenidate and ritalinic acid when that testing is required.

Key Features

• 12-panel multi-drug screening for convenient preliminary testing
• Urine-based testing suitable for authorized screening programs
• Simple collection and testing workflow
• Clear preliminary results designed for easy interpretation
• Convenient multi-analyte format reduces the need for multiple individual screens
• Suitable for workplace, clinical, occupational-health, and treatment-program settings

Designed for Professional Testing

A reliable screening process starts with appropriate specimen collection, handling, storage, and interpretation. Our product supports an organized testing workflow while helping authorized users obtain preliminary screening information efficiently.

For compliance-sensitive applications, all results should be interpreted according to the manufacturer’s instructions and applicable testing policies. A preliminary positive result should be confirmed using an appropriate laboratory method when required.

Ritalin and Specialized Testing

If the objective is specifically to determine whether methylphenidate/Ritalin is present, a standard 12-panel test should not automatically be assumed to provide that information. Specialized laboratory assays are available that specifically test urine for methylphenidate and its metabolite, ritalinic acid, using methods such as LC-MS/MS.

A Smarter Approach to Drug Screening

From routine workplace screening to clinical monitoring, our 12-panel urine drug test offers a practical approach to preliminary multi-drug testing. Its streamlined format helps reduce handling complexity while supporting consistent screening procedures.